ImmunityBio, Inc.IBRXNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+678.6%
5Y CAGR+184.8%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+678.6%/yr
vs +50.3%/yr prior
5Y CAGR
+184.8%/yr
Recent acceleration
Acceleration
+628.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
187.3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$113.29M+668.3%
2024$14.74M+2270.6%
2023$622000.00+159.2%
2022$240000.00-74.3%
2021$934000.00+54.4%
2020$605000.00+1307.0%
2019$43000.00-8.5%
2018$47000.00+4.4%
2017$45000.00+2.3%
2016$44000.00-